322 related articles for article (PubMed ID: 25773741)
1. Histone H3 mutations--a special role for H3.3 in tumorigenesis?
Kallappagoudar S; Yadav RK; Lowe BR; Partridge JF
Chromosoma; 2015 Jun; 124(2):177-89. PubMed ID: 25773741
[TBL] [Abstract][Full Text] [Related]
2. Histone H3 Mutations: An Updated View of Their Role in Chromatin Deregulation and Cancer.
Lowe BR; Maxham LA; Hamey JJ; Wilkins MR; Partridge JF
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31086012
[TBL] [Abstract][Full Text] [Related]
3. Oncohistones and disrupted development in pediatric-type diffuse high-grade glioma.
Ocasio JK; Budd KM; Roach JT; Andrews JM; Baker SJ
Cancer Metastasis Rev; 2023 Jun; 42(2):367-388. PubMed ID: 37119408
[TBL] [Abstract][Full Text] [Related]
4. Histone H3.3 G34 Mutations Alter Histone H3K36 and H3K27 Methylation In Cis.
Shi L; Shi J; Shi X; Li W; Wen H
J Mol Biol; 2018 May; 430(11):1562-1565. PubMed ID: 29689253
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic reprogramming and chromatin accessibility in pediatric diffuse intrinsic pontine gliomas: a neural developmental disease.
Mendez FM; Núñez FJ; Garcia-Fabiani MB; Haase S; Carney S; Gauss JC; Becher OJ; Lowenstein PR; Castro MG
Neuro Oncol; 2020 Feb; 22(2):195-206. PubMed ID: 32078691
[TBL] [Abstract][Full Text] [Related]
6. Pediatric glioma histone H3.3 K27M/G34R mutations drive abnormalities in PML nuclear bodies.
Voon HPJ; Hii L; Garvie A; Udugama M; Krug B; Russo C; Chüeh AC; Daly RJ; Morey A; Bell TDM; Turner SJ; Rosenbluh J; Daniel P; Firestein R; Mann JR; Collas P; Jabado N; Wong LH
Genome Biol; 2023 Dec; 24(1):284. PubMed ID: 38066546
[TBL] [Abstract][Full Text] [Related]
7. Regional identity of human neural stem cells determines oncogenic responses to histone H3.3 mutants.
Bressan RB; Southgate B; Ferguson KM; Blin C; Grant V; Alfazema N; Wills JC; Marques-Torrejon MA; Morrison GM; Ashmore J; Robertson F; Williams CAC; Bradley L; von Kriegsheim A; Anderson RA; Tomlinson SR; Pollard SM
Cell Stem Cell; 2021 May; 28(5):877-893.e9. PubMed ID: 33631116
[TBL] [Abstract][Full Text] [Related]
8. The role of histone modifications and telomere alterations in the pathogenesis of diffuse gliomas in adults and children.
Lee J; Solomon DA; Tihan T
J Neurooncol; 2017 Mar; 132(1):1-11. PubMed ID: 28064387
[TBL] [Abstract][Full Text] [Related]
9. Histone mutations in cancer.
Espinoza Pereira KN; Shan J; Licht JD; Bennett RL
Biochem Soc Trans; 2023 Oct; 51(5):1749-1763. PubMed ID: 37721138
[TBL] [Abstract][Full Text] [Related]
10. Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation.
Funato K; Major T; Lewis PW; Allis CD; Tabar V
Science; 2014 Dec; 346(6216):1529-33. PubMed ID: 25525250
[TBL] [Abstract][Full Text] [Related]
11. Oncohistones in brain tumors: the soil and seed.
Andrade AF; Chen CCL; Jabado N
Trends Cancer; 2023 May; 9(5):444-455. PubMed ID: 36933956
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic Mechanisms of Histone H3 Mutations.
Weinberg DN; Allis CD; Lu C
Cold Spring Harb Perspect Med; 2017 Jan; 7(1):. PubMed ID: 27864305
[TBL] [Abstract][Full Text] [Related]
13. Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma.
Mackay A; Burford A; Carvalho D; Izquierdo E; Fazal-Salom J; Taylor KR; Bjerke L; Clarke M; Vinci M; Nandhabalan M; Temelso S; Popov S; Molinari V; Raman P; Waanders AJ; Han HJ; Gupta S; Marshall L; Zacharoulis S; Vaidya S; Mandeville HC; Bridges LR; Martin AJ; Al-Sarraj S; Chandler C; Ng HK; Li X; Mu K; Trabelsi S; Brahim DH; Kisljakov AN; Konovalov DM; Moore AS; Carcaboso AM; Sunol M; de Torres C; Cruz O; Mora J; Shats LI; Stavale JN; Bidinotto LT; Reis RM; Entz-Werle N; Farrell M; Cryan J; Crimmins D; Caird J; Pears J; Monje M; Debily MA; Castel D; Grill J; Hawkins C; Nikbakht H; Jabado N; Baker SJ; Pfister SM; Jones DTW; Fouladi M; von Bueren AO; Baudis M; Resnick A; Jones C
Cancer Cell; 2017 Oct; 32(4):520-537.e5. PubMed ID: 28966033
[TBL] [Abstract][Full Text] [Related]
14. Targeting Epigenetic Pathways in the Treatment of Pediatric Diffuse (High Grade) Gliomas.
Vanan MI; Underhill DA; Eisenstat DD
Neurotherapeutics; 2017 Apr; 14(2):274-283. PubMed ID: 28233220
[TBL] [Abstract][Full Text] [Related]
15. H2A.Z histone variants facilitate HDACi-dependent removal of H3.3K27M mutant protein in pediatric high-grade glioma cells.
Leszczynska KB; Freitas-Huhtamäki A; Jayaprakash C; Dzwigonska M; Vitorino FNL; Horth C; Wojnicki K; Gielniewski B; Szadkowska P; Kaza B; Nazarian J; Ciolkowski MK; Trubicka J; Grajkowska W; Garcia BA; Majewski J; Kaminska B; Mieczkowski J
Cell Rep; 2024 Feb; 43(2):113707. PubMed ID: 38306270
[TBL] [Abstract][Full Text] [Related]
16. Aberrant DNA repair reveals a vulnerability in histone H3.3-mutant brain tumors.
Giacomini G; Piquet S; Chevallier O; Dabin J; Bai SK; Kim B; Siddaway R; Raught B; Coyaud E; Shan CM; Reid RJD; Toda T; Rothstein R; Barra V; Wilhelm T; Hamadat S; Bertin C; Crane A; Dubois F; Forne I; Imhof A; Bandopadhayay P; Beroukhim R; Naim V; Jia S; Hawkins C; Rondinelli B; Polo SE
Nucleic Acids Res; 2024 Mar; 52(5):2372-2388. PubMed ID: 38214234
[TBL] [Abstract][Full Text] [Related]
17. From Pediatric to Adult Brain Cancer: Exploring Histone H3 Mutations in Australian Brain Cancer Patients.
Grebstad Tune B; Sareen H; Powter B; Kahana-Edwin S; Cooper A; Koh ES; Lee CS; Po JW; McCowage G; Dexter M; Cain L; O'Neill G; Prior V; Karpelowsky J; Tsoli M; Baumbusch LO; Ziegler D; Roberts TL; DeSouza P; Becker TM; Ma Y
Biomedicines; 2023 Oct; 11(11):. PubMed ID: 38001908
[TBL] [Abstract][Full Text] [Related]
18. Diffuse hemispheric glioma with H3-3B G34R mutation: Expanding the spectrum of histone H3 genes in diffuse hemispheric glioma, H3 G34-mutant.
Nazem A; Lavezo J; Abdullaev Z; Aldape K; Quezado M; Cimino PJ; Pratt DW; Jenkins RB; Ida CM
J Neuropathol Exp Neurol; 2023 Dec; 83(1):58-60. PubMed ID: 37878797
[No Abstract] [Full Text] [Related]
19. Mutant ACVR1 Arrests Glial Cell Differentiation to Drive Tumorigenesis in Pediatric Gliomas.
Fortin J; Tian R; Zarrabi I; Hill G; Williams E; Sanchez-Duffhues G; Thorikay M; Ramachandran P; Siddaway R; Wong JF; Wu A; Apuzzo LN; Haight J; You-Ten A; Snow BE; Wakeham A; Goldhamer DJ; Schramek D; Bullock AN; Dijke PT; Hawkins C; Mak TW
Cancer Cell; 2020 Mar; 37(3):308-323.e12. PubMed ID: 32142668
[TBL] [Abstract][Full Text] [Related]
20. Deceptive morphologic and epigenetic heterogeneity in diffuse intrinsic pontine glioma.
Bugiani M; Veldhuijzen van Zanten SEM; Caretti V; Schellen P; Aronica E; Noske DP; Vandertop WP; Kaspers GJL; van Vuurden DG; Wesseling P; Hulleman E
Oncotarget; 2017 Sep; 8(36):60447-60452. PubMed ID: 28947983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
